SENOTHERAPEUTIX
Houston, US · 1 known investors
Find your way into SENOTHERAPEUTIX
Sign up to see every warm intro you have to SENOTHERAPEUTIX
- Paths you didn't know you had: your email and LinkedIn already hold routes to the SENOTHERAPEUTIX team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Senotherapeutix (d/b/a Gerotherapeutix) develops gerotherapeutics based on its MitoXcel geropeptide platform, which targets mitochondrial mechanisms of cellular aging to improve healthspan and extend lifespan. The company operates three subsidiaries spanning longevity therapeutics (Eos Senolytix), oncology peptides (Perseus Senolytix), and controllable gene therapies (Phoenix Senolytix).
Founders & leadership
DS
Dr. SlawinFounder & Leader
Investors · 1
Frequently asked questions
- What does SENOTHERAPEUTIX do?
- Senotherapeutix (d/b/a Gerotherapeutix) develops gerotherapeutics based on its MitoXcel geropeptide platform, which targets mitochondrial mechanisms of cellular aging to improve healthspan and extend lifespan. The company operates three subsidiaries spanning longevity therapeutics (Eos Senolytix), oncology peptides (Perseus Senolytix), and controllable gene therapies (Phoenix Senolytix).
- Who founded SENOTHERAPEUTIX?
- SENOTHERAPEUTIX was founded by Dr. Slawin.
- Who are SENOTHERAPEUTIX's investors?
- SENOTHERAPEUTIX's investors include Rapha Capital Management, LLC.
- Where is SENOTHERAPEUTIX headquartered?
- SENOTHERAPEUTIX is headquartered in Houston, US.